About Us
Research
Participants
Investigators
News & Events
Initiatives
Members
Frequently Asked Questions
All Studies
Current Studies
Ask Dr Sepulveda
Self Help Tools
All Studies
IMPAACT 1088 Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Swine-Origin H1N1 Influenza Vaccine in HIV-1 Perinatally Infected Children and Youth
Sharon Nachman, MD
Protocol Number: 09-597-36
Contact: Denise Ferraro RN, 631-444-8225
A Phase II Study to Assess the Safety and Immunogenicity of a Swine-Origin Sanofi Pasteur Unadjuvanted Inactivated H1N1 Influenza Vaccine in HIV-1 Infected Pregnant Women
Sharon Nachman, MD
Protocol Number: 09-596-36
Contact: Denise Ferraro RN, 631-444-8225
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus in HIV-1-Infected Females A5240
Sharon Nachman, MD
Protocol Number: 09-589-36
Contact: Denise Ferraro, 631-444-8225
Injection of Sterile Saline onto the Capsule of Normal Shoulders
Marie Badalamente, MD
Protocol Number: 09-584-11
Contact: Dr. Badalamente, 631 444-2215
Validation of Dyna-CT Perfusion in Patients with Ischemic Cerebrovascular Disease
Henry Woo, MD
Protocol Number: 09-583-183
Contact: Susan Fiore at 631-444-9425
A study of resilience enhancement using a mind-body approach in patients with implantable cardioverter defibrillator.
Corrine Jurgens, PhD
Protocol Number: 09-582-160
Contact: Linda Vlay, MS.NPP at 631-474-1444
Body weight supported treadmill training with patients post lower extremity amputation
Eric Lamberg
Protocol Number: 09-579-184
Contact: GCRC 631-444-1200
Prospective memory Changes in Pediatric Patients with Diabetes Mellitus Type 1
Thomas Wilson, MD
Protocol Number: 09-578-12
Contact: 631-444-3429
Stenting and Aggressive Medical Management for Preventing Recurrent stroke in Intracranial Stenosis
Henry Woo, MD
Protocol Number: 09-577-183
Contact: Susan M. Fiore, 631-444-9425
Phase I/II Open-Label study to Evaluate the Pharmacokinetics, Safety, Tolerability, and Antiviral Activity of Vicriviroc (SCH-417690) A Novel CCR5 Antagonist in Combination Regimens in HIV infected Antiretroviral Therapy Experienced Children and Adolescents
Sharon A. Nachman, MD
Protocol Number: 08-575-36
Contact: Denise Ferraro, RN 631-444-8225
1 of 17
Next
Last